Sorry for your friend. This is the original article: http://www.pnas.org/content/109/17/6662 http://www.pnas.org/content/109/17/6662 You can actually get the

Sorry for your friend. This is the original article: http://www.pnas.org/content/109/17/6662 http://www.pnas.org/content/109/17/6662 You can actually get the antibody yourself, FTA: "The anti-hCD47 (B6H12) hybridoma was obtained from the ATCC" [http://www.lgcstandards-atcc.org/Products/All/HB-9771.aspx http://www.lgcstandards-atcc.org/Products/All/HB-9771.aspx] Purifying it is easy, if you have a lab. However... you can't use that antibody directly in humans, since it is a mouse antibody, which the human immune system will recognize as foreign. So, even if this treatment were to work, it is necessary is to first "humanize" the antibody so it won't be rejected, and then you can see what effect you get in a clinical trial. I imagine this is what the $20mil funding is for. You can find clinical trials for new drugs here: http://clinicaltrials.gov/ http://clinicaltrials.gov/